Reports and Briefs on Pharmaceuticals and Healthcare

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

China Hospital Directory

Listing of 21,729 hospitals in China, providing the following fields: name, province, state, telephone number, hospital grade, hospital tier, bed count, physician count, revenue from medical services, and revenue from pharmaceutical sales.

Published By Datamonitor
11 Dec 2013 $1520
Buy
Report
Report

Rheumatoid Arthritis - Pipeline

Review of candidates in development for rheumatoid arthritis across the US, Japan, and five major EU markets.

Published By Datamonitor
03 Dec 2013 $2000
Buy
Report
Report

Rheumatoid Arthritis - Marketed Drugs

In-depth analysis of marketed drugs for rheumatoid arthritis, including lifecycle management strategies, new clinical data and an evaluation of clinical and commercial drug attributes to understand competitiveness in the marketplace.

Published By Datamonitor
03 Dec 2013 $2000
Buy
Report
Report

Rheumatoid Arthritis - Forecast

Becoming increasingly difficult for developers of novel products to penetrate the rheumatoid arthritis market

Published By Datamonitor
03 Dec 2013 $2000
Buy
Report
Report

Oncology Overview - Marketed Drugs

Oncology Overview Marketed Drugs

Published By Datamonitor
03 Dec 2013 $2000
Buy
Report
Report

Diabetes Type 2 - Forecast

Patient-based forecast of the Type 2 Diabetes Market 2013-22

Published By Datamonitor
03 Dec 2013 $2000
Buy
Report
Report

Epidemiology of Hepatocellular Cancer in China

The size of HCC patient population in China provides a lucrative market for anti-cancer drugs. This epidemiologic analysis uses historical cancer incidence data to estimate and forecast HCC patient populations in China between 2012 and 2030.

Published By Datamonitor
25 Apr 2013 $2800
Buy
Report
Report

Hepatocellular cancer: Nexavar & Pipeline products

Nexavar is pursuing line extensions to tighten its grip on the HCC treatment market

Published By Datamonitor
24 Apr 2013 $2000
Buy
Report
Report

The Hepatitis C Market Outlook to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
17 Apr 2013 $2800
Buy
Report
Report

Advances in Gene Therapy

Trends in gene vector technologies and insight into their application in various therapy areas.

Published By Datamonitor
25 Mar 2013 $2800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.